Arcadia Biosciences, Inc. (RKDA) Gross margin 2017–2025
Arcadia Biosciences, Inc. (RKDA) gross margin by fiscal year — reported gross profit divided by reported revenue.
36.2%FY2025 · since FY2017: 93.0% → 36.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 36.2% | -5.0 pp |
| FY2024 | 41.3% | -9.9 pp |
| FY2023 | 51.2% | +33.4 pp |
| FY2022 | 17.8% | +46.2 pp |
| FY2021 | -28.4% | -63.7 pp |
| FY2020 | 35.3% | — |
| FY2017 | 93.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RKDA financial trends
RKDA RevenueRKDA Net incomeRKDA Net marginRKDA Gross profitRKDA Operating incomeRKDA Operating marginRKDA Operating cash flowRKDA Free cash flowRKDA Capital expendituresRKDA Return on equityRKDA Stock buybacksRKDA Dividends paidRKDA Total assetsRKDA Total liabilitiesRKDA Shareholders’ equityRKDA overview →